MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
European Urology Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

180 results · 1 filter active ·
Results by year
20182025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
180 works in the cohort · of 4,299,418page 2 of 4

Labels cover 0 of 180 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 180 of 180 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Matthew Scott Ernst, Vishal Navani, J. Connor Wells, Ziad Bakouny, Frede Donskov +14 more
2023· article· en· European Urology Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
27
citations
affunlabeled
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
Noel W. Clarke, Andrew J. Armstrong, Mototsugu Oya, Neal D. Shore, Giuseppe Procopio, João Daniel Guedes +12 more
2024· article· en· European Urology Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
17
citations
affunlabeled
Adaptive Immunity in Genitourinary Cancers
Madhuri Koti, Trinity J. Bivalacqua, Peter C. Black, Toni Cathomen, Matthew D. Galsky, James L. Gulley +5 more
2023· review· en· European Urology Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
17
citations
← previousnext →

How this was built: Screen · Findings · About